China Approves Clinical Trials of COVID-19 Vaccines

Grant Boone
April 15, 2020

In the second phase, the vaccine will be examined mainly for its effectiveness. "We know that COVID-19 spreads fast, and we know that it is deadly - 10 times deadlier than the 2009 flu pandemic".

The World Health Organization this week counted more than five dozen other vaccine candidates in earlier stages of development being pursued around the world.

The vaccine developed by CanSino Biologics uses a non-replicating viral vector platform, while it is an adenovirus type 5 vector vaccine.

In the US, a shot made by the National Institutes of Health and Moderna Inc. isn't far behind.

Coronavirus is the third outbreak of the 21st century, behind SARS and MERS which still don't have approved vaccines.

USA company Inovio Pharmaceuticals is also conducting human trials and is working with Chinese researchers to begin a study with the drug in China.

Wuhan Institute of Virology: Origin of Coronavirus or Conspiracy Nonsense?
There has been no scientific or medical conclusion yet on the origin of Covid-19, as relevant tracing work is still under way. Some experts say that these concerns over whether the virus could have escaped from a Chinese lab should be investigated.

CanSino has said in a listing with the Hong Kong Stock Exchange that they are now planning to move to phase 2 of clinical trials in China soon with the genetically engineered vaccine that is considered to be a candidate. The DNA vaccine candidate, named INO-4800, has shown promising results from preclinical studies performed on animals. NVX-CoV2373 is a stable prefusion protein made using the company's nanoparticle technology.

"We call mRNA the software of life". All new cases are citizens of China, who returned to the country from Russian Federation, said Tuesday the state media. "It just carries a different genetic sequence depending on the disease", Stéphane Bancel, CEO of the company, Moderna, said.

An effective vaccine against the novel coronavirus is unlikely to be available until the spring of 2021, World Health Organization (WHO) spokesperson, Dr. Margaret Harris, has warned.

Researchers are pushing to bring a vaccine to market within the year - which would be a remarkable feat given that such drugs typically take more than a decade to make it to the public, Bloomberg reported.

COVID-19 originated in China's Wuhan last December, but the epicentre of the disease later shifted to Europe and now the United States has registered the highest number of coronavirus infections.

Spain and Italy follow with 174,060 and 162,488 people infected, respectively.

Other reports by

Discuss This Article